mAbsolve employee Michael Fiebig announced his last day at Absolute Antibody.

Public source

Publisher name

Public post

Today was my last day at Absolute Antibody. The end of 12 years of not just building a recombinant antibody catalogue and services business, but a journey of driving ado…

Log in to read the full post

Company

mAbsolve

The only Fc silencing technology that is truly silent.

Industry
Biotechnology Research
Location
Oxford, GB
Company size
2–10 employees

About mAbsolve

Our founders were pioneers of monoclonal antibody therapy, bringing to the clinic the first humanised antibody, the first made in CHO cells, the first bispecific and the first aglycosylated antibody. Now we have developed a new Fc variant which is more comprehensively silenced than previous antibodies. It is able to reduce unwanted inflammatory responses from the next generation of antibody-based drugs. We are building partnerships with Universities, Biotech and Pharma companies to make this new technology widely available.

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.